Cancer Diagnostics
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
400
NCT06298799
GENETIC VARIABILITY TO GLP1 TREATMENT
Phase: N/A
Role: Lead Sponsor
Start: Oct 1, 2023
Completion: Jan 1, 2025
Loading map...